Leiomyosarcoma - 29 Studies Found
| Completed |
: Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas : Leiomyosarcoma : 2011-08-10 : Drug: pazopanib + gemcitabine pazopanib tablets (200mg) per os, 800mg/day continuously gemcitabine IV, 2 |
| Active, not recruiting |
: Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma : Leiomyosarcoma : 2014-09-23 :
|
| Completed |
: Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma : Leiomyosarcoma : 2009-03-04 : Drug: letrozole Taken orally once a day continuously |
| Withdrawn |
: Pazopanib for Treating Uterine Leiomyosarcoma : Uterine Leiomyosarcoma : 2015-02-17 : Drug: Pazopanib |
| Active, not recruiting |
: SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma : Metastatic Leiomyosarcoma : 2014-11-21 :
|
| Suspended |
: Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma : Uterine Corpus Leiomyosarcoma : 2015-04-23 :
|
| Completed |
: Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma :
|
| Completed |
: Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma :
: 2014-09-05 : Drug: Trabectedin Trabectedin administered at a dose of 1.5 mg/m2 - 1.3 mg/m2 (at investigator's discret |
| Not yet recruiting |
: Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma : Uterine or Soft Tissue Leiomyosarcoma : 2016-12-13 :
|
| Completed |
: A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma : Advanced Liposarcoma or Leiomyosarcoma : 2011-04-26 :
|